These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5680040)

  • 1. Synthesis of potential antimalarial agents. II. 6,8-Disubstituted pyrido(2,3-b)pyrazines.
    Temple C; Rose JD; Elliott RD; Montgomery JA
    J Med Chem; 1968 Nov; 11(6):1216-8. PubMed ID: 5680040
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of potential antimalarial agents. V. Pyrido[2,3-b]pyrazines.
    Temple C; Rose JD; Elliott RD; Montgomery JA
    J Med Chem; 1970 Sep; 13(5):853-7. PubMed ID: 5458369
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of potential antimalarial agents. VI. Preparation of 3-(p-chlorophenyl)-8-(4-(diethylamino)-1-methylbutyl()amino) pyrido(2,3-b)pyrazine.
    Temple C; Rose JD; Montgomery JA
    J Med Chem; 1970 Nov; 13(6):1234-5. PubMed ID: 5488799
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis and antibacterial properties of pyrido[2,3-b]pyrazine derivatives].
    Miyazawa T; Takabatake T; Hasegawa M
    Yakugaku Zasshi; 1997 Feb; 117(2):126-32. PubMed ID: 9084228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antimalarial activity, and molecular modeling of new pyrrolo[1,2-a]quinoxalines, bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines.
    Guillon J; Grellier P; Labaied M; Sonnet P; Léger JM; Déprez-Poulain R; Forfar-Bares I; Dallemagne P; Lemaître N; Péhourcq F; Rochette J; Sergheraert C; Jarry C
    J Med Chem; 2004 Apr; 47(8):1997-2009. PubMed ID: 15055999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some pyrido- and pyrazino-benzimidazole derivatives and their antifungal activity.
    Demirayak S; Güven K
    Pharmazie; 1995 Aug; 50(8):527-9. PubMed ID: 7568315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of pyrido quinoxalines as new family of antimalarial agents.
    Chandra Shekhar A; Shanthan Rao P; Narsaiah B; Allanki AD; Sijwali PS
    Eur J Med Chem; 2014 Apr; 77():280-7. PubMed ID: 24650715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential antimitotic agents. Synthesis of some ethyl benzopyrazin-7-ylcarbamates, ethyl pyrido[3,4-b]pyrazin-7-ylcarbamates, and ethyl pyrido[3,4-e]-as-triazin-7-ylcarbamates.
    Temple C; Rener GA
    J Med Chem; 1990 Nov; 33(11):3044-50. PubMed ID: 2231603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syntheses of pyrido(2,3-b)pyrazine derivatives (author's transl)].
    Tanaka T; Narita S
    Yakugaku Zasshi; 1975 Sep; 95(9):1092-7. PubMed ID: 1238547
    [No Abstract]   [Full Text] [Related]  

  • 10. Folate antagonists. 4. Antimalarial and antimetabolite effects of 2,4-diamino-6-((benzyl)amino)pyrido(2,3-d)-pyrimidines.
    Davoll J; Clarke J; Elslager EF
    J Med Chem; 1972 Aug; 15(8):837-9. PubMed ID: 5044297
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of pyridines and pyrazines using an intramolecular hydroamination-based reaction sequence.
    Rizk T; Bilodeau EJ; Beauchemin AM
    Angew Chem Int Ed Engl; 2009; 48(44):8325-7. PubMed ID: 19784988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on pyrazine derivatives. XV. Synthesis and tuberculostatic effect of imidazoline pyrazines and imidazoline pyridines].
    Foks H; Janowiec M
    Acta Pol Pharm; 1982; 39(1-3):79-82. PubMed ID: 6817592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pyrido [3,2-b]indol-4-yl-amines--synthesis and investigation of activity against malaria].
    Görlitzer K; Kramer C; Meyer H; Walter RD; Jomaa H; Wiesner J
    Pharmazie; 2004 Apr; 59(4):243-50. PubMed ID: 15125565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarials. 6. Synthesis, antimalarial activity, and configurations of racemic alpha-(2-piperidyl)-4-pyridinemethanols.
    LaMontagne MP; Markovac A; Blumbergs P
    J Med Chem; 1974 May; 17(5):519-23. PubMed ID: 4598133
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological activity of new potential antimalarial: 1H-pyrazolo[3,4-b]pyridine derivatives.
    Dias LR; Freitas AC; Barreiro EJ; Goins DK; Nanayakkara D; McChesney JD
    Boll Chim Farm; 2000; 139(1):14-20. PubMed ID: 10829547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Acetylpyridine thiosemicarbazones. 2. N4,N4-Disubstituted derivatives as potential antimalarial agents.
    Klaymann DL; Scovill JP; Bartosevich JF; Mason CJ
    J Med Chem; 1979 Nov; 22(11):1367-73. PubMed ID: 392099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial pyrido[1,2-a]benzimidazoles.
    Ndakala AJ; Gessner RK; Gitari PW; October N; White KL; Hudson A; Fakorede F; Shackleford DM; Kaiser M; Yeates C; Charman SA; Chibale K
    J Med Chem; 2011 Jul; 54(13):4581-9. PubMed ID: 21644541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Acetylpyridine thiosemicarbazones. 10. 2-Propionyl-, 2-butyryl-, and 2-(2-methylpropionyl)pyridine thiosemicarbazones as potential antimalarial agents.
    Klayman DL; Mason CJ; Scovill JP
    Arzneimittelforschung; 1984; 34(12):1701-3. PubMed ID: 6397197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class of extended pi-conjugated systems: one-pot synthesis of bis-3-aminoimidazo[1,2-a]pyridines, pyrimidines and pyrazines.
    Shaabani A; Soleimani E; Maleki A; Moghimi-Rad J
    Mol Divers; 2009 May; 13(2):269-74. PubMed ID: 19048381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction].
    Kékesi L; Sipos A; Németh G; Dancsó A; Illyés E; Boros S; Breza N; Nemes Z; Hegymegi-Barakonyi B; Pató J; Greff Z; Kéri G; Őrfi L
    Acta Pharm Hung; 2014; 84(3):91-104. PubMed ID: 25470976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.